Is a Globus Medical, Inc. (GMED) Promising Medical Stock with Growth Potential?
We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to take a look at where Globus Medical, Inc. (NYSE:GMED) stands against other most promising medical stocks.
Globus Medical, Inc. (GMED) Q3 2024 Earnings Call Transcript
Welcome to Globus Medical's Third Quarter 2024 Earnings Call. At this time, all lines will be on mute and a Q&A session will be held after the prepared remarks. I will now turn the call over to Brian Kearns,
Globus Medical (GMED) Beats Q3 Earnings and Revenue Estimates
Globus Medical (GMED) came out with quarterly earnings of $0.83 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.57 per share a year ago. These figures are adjusted for non-recurring items.
Globus Medical Inc (GMED) Posted 1.82% Profit Margin Last Year—Can It Hold Up?
On Wednesday, Globus Medical Inc (GMED) stock saw a modest uptick, ending the day at $75.07 which represents a slight increase of $0.78 or 1.05% from the prior close of $74.29. The stock opened at $74.
Coupang (CPNG) Q3 2024 Earnings Call Transcript
At this time, I would like to welcome everyone to the Coupang 2024 third-quarter earnings conference call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks,
Sotera Health Company (SHC) Q3 2024 Earnings Call Transcript
Good morning, and welcome to the Sotera Health Third Quarter 2024 Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions.
AbCellera Biologics (ABCL) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Call Nov 04, 2024, 5:00 p.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Partici
Karyopharm Therapeutics (KPTI) Q3 2024 Earnings Call Transcript
At this time, I would like to welcome everyone to Karyopharm Therapeutics third quarter 2024 financial results conference call. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company's request.
Yahoo Finance2h
Globus Medical (GMED) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended September 2024, Globus Medical (GMED) reported revenue of $625.71 million, up 63.1% over the same period last year. EPS came in at $0.83, compared to $0.57 in the year-ago ...
Business Insider9h
Globus Medical Reports Third Quarter 2024 Results
AUDUBON, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September ...
Houston Chronicle1d
Globus Medical: Q3 Earnings Snapshot
AUDUBON, Pa. (AP) — AUDUBON, Pa. (AP) — Globus Medical Inc. (GMED) on Tuesday reported third-quarter net income of $51.8 million. On a per-share basis, the Audubon, Pennsylvania-based company said ...
Globus Medical, Inc.'s (NYSE:GMED) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors’ money. In simpler terms, it measures the profitability of a company in relation to ...
Nasdaq7d
Is GMED Stock a Smart Addition to Your Portfolio Right Now?
Globus Medical, Inc.’s GMED merger with NuVasive is expected to generate significant synergies, enhance its globalization initiatives, expand customer access and bolster ties with surgeons.
Notable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Microchip Technology (MCHP), consensus 43c… ...
Morningstar5d
Globus Medical Inc Class A
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...